These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 2783645)
1. Effects of in vivo administration of anti-Ia antibodies on contact sensitivity. Aberer W; Katz SI Arch Dermatol; 1989 Feb; 125(2):280-4. PubMed ID: 2783645 [TBL] [Abstract][Full Text] [Related]
2. In vivo treatment with anti-I-A antibodies: differential effects on Ia antigens and antigen-presenting cell function of spleen cells and epidermal Langerhans cells. Aberer W; Kruisbeek AM; Shimada S; Katz SI J Immunol; 1986 Feb; 136(3):830-6. PubMed ID: 3455705 [TBL] [Abstract][Full Text] [Related]
3. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Ma J; Wang JH; Guo YJ; Sy MS; Bigby M Cell Immunol; 1994 Oct; 158(2):389-99. PubMed ID: 7923390 [TBL] [Abstract][Full Text] [Related]
4. Skin application of the nonsteroidal anti-inflammatory drug ketoprofen downmodulates the antigen-presenting ability of Langerhans cells in mice. Atarashi K; Kabashima K; Akiyama K; Tokura Y Br J Dermatol; 2008 Aug; 159(2):306-13. PubMed ID: 18565185 [TBL] [Abstract][Full Text] [Related]
5. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576 [TBL] [Abstract][Full Text] [Related]
6. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. Peeler JS; Niederkorn JY J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767 [TBL] [Abstract][Full Text] [Related]
7. [Induction of TNCB contact sensitivity by TNP-modified epidermal cells and spleen cells--immunological functions of Ia antigen on hapten-modified cells in the induction of contact sensitivity (author's transl)]. Ikezawa Z; Satoh M; Nagai R; Okuda K Nihon Hifuka Gakkai Zasshi; 1981 Jun; 91(7):729-37. PubMed ID: 6977051 [No Abstract] [Full Text] [Related]
8. Pentamidine isethionate reduces Ia expression and antigen presentation by Langerhans cells and inhibits the contact hypersensitivity reaction. Blaylock BL; Kouchi Y; Comment CE; Corsini E; Rosenthal GJ; Luster MI J Immunol; 1991 Oct; 147(7):2116-21. PubMed ID: 1833452 [TBL] [Abstract][Full Text] [Related]
9. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells. Katayama I; Matsunaga T; Yokozeki H; Nishioka K Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antigen-presenting capacity of cultured Langerhans' cells is associated with markedly increased expression of Ia antigen. Shimada S; Caughman SW; Sharrow SO; Stephany D; Katz SI J Immunol; 1987 Oct; 139(8):2551-5. PubMed ID: 3498764 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C transduces the signal for Langerhans' cell migration from the epidermis. Halliday GM; Lucas AD Immunology; 1993 Aug; 79(4):621-6. PubMed ID: 8406587 [TBL] [Abstract][Full Text] [Related]
12. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088 [TBL] [Abstract][Full Text] [Related]
13. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. Enk AH; Angeloni VL; Udey MC; Katz SI J Immunol; 1993 May; 150(9):3698-704. PubMed ID: 8473727 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. Enk AH; Angeloni VL; Udey MC; Katz SI J Immunol; 1993 Sep; 151(5):2390-8. PubMed ID: 8103065 [TBL] [Abstract][Full Text] [Related]
15. Role of dermal cells from normal and ultraviolet B-damaged skin in induction of contact hypersensitivity and tolerance. Kurimoto I; Arana M; Streilein JW J Immunol; 1994 Apr; 152(7):3317-23. PubMed ID: 8144917 [TBL] [Abstract][Full Text] [Related]
16. Soluble factors in tolerance and contact sensitivity to DNFB in mice. VI. Cellular and lymphokine requirements for stimulating suppressor factor production in vitro. Fairchild RL; Moorhead JW J Immunol; 1986 Oct; 137(7):2125-31. PubMed ID: 2944949 [TBL] [Abstract][Full Text] [Related]
17. Influence of accessory cell and T cell surface antigens on mitogen-induced IL 2 receptor expression. Malek TR; Chan C; Glimcher LH; Germain RN; Shevach EM J Immunol; 1985 Sep; 135(3):1826-33. PubMed ID: 3926885 [TBL] [Abstract][Full Text] [Related]
18. [Role of the Langerhans cells in contact allergy]. Baer RL Z Hautkr; 1984 Sep; 59(18):1205-8. PubMed ID: 6437091 [No Abstract] [Full Text] [Related]